Evidation Health, a startup that provides technology for virtual clinical trials, raised $45 million in series D funding. The company plans to use the funds to offer virtual health programs to research participants.
Notable CEO Matthew De Silva said the company has been able to successfully replicate its automated system, allowing for the export of the company's technology and growth of its commercial use cases.
Explore top PTSD treatment centers in Arizona, offering personalized care, holistic therapies and expert support to help individuals heal and reclaim their lives.
B Capital Group Partner Gavin Teo said tax reform and a more liberal FDA are helping to make technologies supporting drug research and development more attractive to investors.
Evidation Health does clinical validation of digital health tools to help payers, providers and health systems handle the tough job of sifting through them to identify which ones are most appropriate for their patients and members.